Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients. 2009

Antoine Bénard, and Florence Damond, and Pauline Campa, and Gilles Peytavin, and Diane Descamps, and Caroline Lascoux-Combes, and Audrey Taieb, and François Simon, and Brigitte Autran, and Françoise Brun-Vézinet, and Geneviève Chêne, and Sophie Matheron, and
INSERM U897, CIC-EC 7, Université Victor Segalen Bordeaux 2, France. antoine.benard@isped.u-bordeaux2.fr

In 29 antiretroviral-naive HIV-2-infected patients starting lopinavir/ritonavir-containing regimen, the median CD4 cell count change from baseline (142 cells/microl) was +71 cells/microl at week 24 and +132 cells/microl at week 96. Seventeen (59%) patients had a CD4 cell count increase of at least 50 cells/microl and undetectable HIV-2 RNA at week 24 and were considered as responders to treatment. This sustained elevation of CD4 cell count in the first 2 years of combination antiretroviral therapy shows the potential for lopinavir/ritonavir regimens as first-line therapy in HIV-2 infection.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Antoine Bénard, and Florence Damond, and Pauline Campa, and Gilles Peytavin, and Diane Descamps, and Caroline Lascoux-Combes, and Audrey Taieb, and François Simon, and Brigitte Autran, and Françoise Brun-Vézinet, and Geneviève Chêne, and Sophie Matheron, and
April 2004, Antiviral research,
Antoine Bénard, and Florence Damond, and Pauline Campa, and Gilles Peytavin, and Diane Descamps, and Caroline Lascoux-Combes, and Audrey Taieb, and François Simon, and Brigitte Autran, and Françoise Brun-Vézinet, and Geneviève Chêne, and Sophie Matheron, and
January 2008, AIDS (London, England),
Antoine Bénard, and Florence Damond, and Pauline Campa, and Gilles Peytavin, and Diane Descamps, and Caroline Lascoux-Combes, and Audrey Taieb, and François Simon, and Brigitte Autran, and Françoise Brun-Vézinet, and Geneviève Chêne, and Sophie Matheron, and
January 2007, HIV medicine,
Antoine Bénard, and Florence Damond, and Pauline Campa, and Gilles Peytavin, and Diane Descamps, and Caroline Lascoux-Combes, and Audrey Taieb, and François Simon, and Brigitte Autran, and Françoise Brun-Vézinet, and Geneviève Chêne, and Sophie Matheron, and
April 2004, AIDS (London, England),
Antoine Bénard, and Florence Damond, and Pauline Campa, and Gilles Peytavin, and Diane Descamps, and Caroline Lascoux-Combes, and Audrey Taieb, and François Simon, and Brigitte Autran, and Françoise Brun-Vézinet, and Geneviève Chêne, and Sophie Matheron, and
August 2009, AIDS (London, England),
Antoine Bénard, and Florence Damond, and Pauline Campa, and Gilles Peytavin, and Diane Descamps, and Caroline Lascoux-Combes, and Audrey Taieb, and François Simon, and Brigitte Autran, and Françoise Brun-Vézinet, and Geneviève Chêne, and Sophie Matheron, and
May 2014, AIDS research and human retroviruses,
Antoine Bénard, and Florence Damond, and Pauline Campa, and Gilles Peytavin, and Diane Descamps, and Caroline Lascoux-Combes, and Audrey Taieb, and François Simon, and Brigitte Autran, and Françoise Brun-Vézinet, and Geneviève Chêne, and Sophie Matheron, and
September 2007, Journal of acquired immune deficiency syndromes (1999),
Antoine Bénard, and Florence Damond, and Pauline Campa, and Gilles Peytavin, and Diane Descamps, and Caroline Lascoux-Combes, and Audrey Taieb, and François Simon, and Brigitte Autran, and Françoise Brun-Vézinet, and Geneviève Chêne, and Sophie Matheron, and
June 2005, The Journal of infectious diseases,
Antoine Bénard, and Florence Damond, and Pauline Campa, and Gilles Peytavin, and Diane Descamps, and Caroline Lascoux-Combes, and Audrey Taieb, and François Simon, and Brigitte Autran, and Françoise Brun-Vézinet, and Geneviève Chêne, and Sophie Matheron, and
August 2014, The Pediatric infectious disease journal,
Antoine Bénard, and Florence Damond, and Pauline Campa, and Gilles Peytavin, and Diane Descamps, and Caroline Lascoux-Combes, and Audrey Taieb, and François Simon, and Brigitte Autran, and Françoise Brun-Vézinet, and Geneviève Chêne, and Sophie Matheron, and
March 2003, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses,
Copied contents to your clipboard!